论文部分内容阅读
目的探讨金莲清热泡腾片与利巴韦林颗粒治疗小儿急性上呼吸道感染疾病临床疗效。方法对照组患儿单纯使用利巴韦林颗粒治疗;研究组患儿在进行上述治疗基础上,加用金莲清热泡腾片联合治疗,对两组患儿疗效进行统计学分析后得出结论。结果研究组患儿临床治疗总有效率(93.33%)显著高于对照组(70.00%),且对比结果差异具有统计学意义(P<0.05)。结论应用利巴韦林颗粒联合金莲清热泡腾片治疗小儿急性上呼吸道感染疾病,可达到满意临床疗效,且安全性较高,值得临床推广应用。
Objective To investigate the clinical effect of Qinglian effervescent tablet and ribavirin on children with acute upper respiratory tract infection. Methods The control group of children treated with ribavirin alone; study group children on the basis of the above treatment, plus the Golden Lotus heat effervescent tablets combined treatment, the efficacy of the two groups of children after a statistical analysis concluded. Results The total effective rate (93.33%) in clinical study group was significantly higher than that in control group (70.00%), and the difference was statistically significant (P <0.05). Conclusion The combination of ribavirin granules and neroli tablet in the treatment of children with acute upper respiratory tract infection can achieve satisfactory clinical efficacy and safety, which is worthy of clinical application.